cytokine induced killer cells

DRUG2 trials

Sponsors

Stanford University, Siriraj Hospital

Conditions

Blood and Marrow Transplant (BMT)CholangiocarcinomaMultiple MyelomaNeuroblastoma

Phase 1

Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation

CompletedNCT00185757

Stanford UniversityBlood and Marrow Transplant (BMT), Multiple Myeloma

Start: 2004-06-01End: 2012-12-01Updated: 2026-06-04

The Adoptive Immunotherapy for Solid Tumors Using Modified Autologous CIK Cells

Enrolling by invitationNCT01868490

Siriraj HospitalCholangiocarcinoma, Neuroblastoma

Start: 2009-04-17End: 2028-05-30Target: 20Updated: 2025-02-10